Status:
COMPLETED
Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
Lead Sponsor:
Gynecologic Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Carcinoma
Fallopian Tube Carcinoma
Eligibility:
FEMALE
30+ years
Brief Summary
This clinical trial is studying the incidence of cancer in women at increased genetic risk of ovarian cancer. Gathering information about genetic factors in women with an increased risk of ovarian can...
Detailed Description
PRIMARY OBJECTIVES: I. To determine the prospective incidence of ovarian cancer, fallopian tube cancer, breast cancer, primary peritoneal cancer, and all cancer among women at increased risk of ovari...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Enrolled on GOG-0199
- Completed the original 5-year follow-up period OR is off-study due to pregnancy or development of a new cancer
- Completed the Off-Study form (Form Q0-0199 submitted via SEDES)
- No patients who were off-study before the end of the initial 5-year follow-up period (found to be ineligible or consent withdrawal)
Exclusion
Key Trial Info
Start Date :
June 7 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 10 2020
Estimated Enrollment :
1916 Patients enrolled
Trial Details
Trial ID
NCT01139957
Start Date
June 7 2010
End Date
April 10 2020
Last Update
September 2 2020
Active Locations (141)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States, 35233
2
Gynecologic Oncology Group of Arizona
Phoenix, Arizona, United States, 85012
3
Mayo Clinic in Arizona
Scottsdale, Arizona, United States, 85259
4
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States, 90095